tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Corvus Pharmaceuticals Reports Promising Phase 1 Trial Results
PremiumCompany AnnouncementsCorvus Pharmaceuticals Reports Promising Phase 1 Trial Results
2M ago
Corvus announces new interim data from Phase 1 trial of soquelitinib
Premium
The Fly
Corvus announces new interim data from Phase 1 trial of soquelitinib
2M ago
Corvus Pharmaceuticals price target lowered to $11 from $12 at Mizuho
Premium
The Fly
Corvus Pharmaceuticals price target lowered to $11 from $12 at Mizuho
3M ago
Corvus Pharmaceuticals: Promising AD Treatment Developments and Strategic Expansion Justify Buy Rating
PremiumRatingsCorvus Pharmaceuticals: Promising AD Treatment Developments and Strategic Expansion Justify Buy Rating
3M ago
Corvus Pharmaceuticals Reports Promising Q1 2025 Results
Premium
Company Announcements
Corvus Pharmaceuticals Reports Promising Q1 2025 Results
3M ago
Corvus Pharmaceuticals Reports Positive Phase 1 Trial Results
Premium
Company Announcements
Corvus Pharmaceuticals Reports Positive Phase 1 Trial Results
3M ago
Corvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
PremiumThe FlyCorvus Pharmaceuticals price target raised to $15 from $14 at Oppenheimer
5M ago
Corvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
Premium
Company Announcements
Corvus Pharmaceuticals Reports 2024 Financial Results and Clinical Progress
5M ago
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
Premium
The Fly
Corvus Pharmaceuticals reports Q4 EPS (18c), consensus (12c)
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100